1 / 5

Preclinical Imaging Market Size, Share, Forecast 2029

Preclinical Imaging Market By Type of Product (Imaging Modalities, Single Photon emission computed tomography (SPECT), Micro Computed Tomography (Micro-CT), Magnetic Particle Imaging, Magnetic Resonance Imaging (MRI), Optical Imaging, X-Ray Imaging, Positron Emission Tomography (PET), Ultrasound , Reagents and Kits, Others), By Application (Research and Development, Drug Discovery), By End User (Biotech Companies, Pharmaceutical companies, Research institutes), and Geography.

MathurReshma
Télécharger la présentation

Preclinical Imaging Market Size, Share, Forecast 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Preclinical Imaging Market (2023-2029)

  2. Market Overview: Preclinical Imaging Market size was valued at USD 870.4 million in 2022, growing at a CAGR of 7.1% during the forecast period 2023-2029. The Preclinical Imaging Market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the Preclinical Imaging Market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description

  3. Market Segments: The Preclinical Imaging Market has been fragmented based on: 1) By Type of Product: Imaging Modalities, Single Photon emission computed tomography (SPECT), Micro Computed Tomography (Micro-CT), Magnetic Particle Imaging, Magnetic Resonance Imaging (MRI), Optical Imaging, X-Ray Imaging, Positron Emission Tomography (PET), Ultrasound , Reagents and Kits, Others 2) By Application:Research and Development, Drug Discovery 3) By End-User : Biotech Companies, Pharmaceutical companies, Research institutes Request Sample Report

  4. Key Players: • Some of the major key players in the Preclinical Imaging Market are: • FUJIFILM Holdings Corporation (Japan), • MR Solutions (U.K.), • PerkinElmer Inc. (U.S.), • Siemens Ltd (U.S.), • MiltenyiBiotec (Germany), • Aspect Imaging (Canada), • MILabs B.V. (Netherlands), • Bruker Corporation (U.S.), • Mediso Ltd. (Hungary), • TriFoil Imaging (U.S.), • Carestream Health (U.S.) • Request Sample Report

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553

More Related